Pharmaceuticals, Biotechnology and Life Sciences
– Demonstrates Evidence of Production of Antibodies and T Cell Responses in Mice: Shows Strong Antibody Responses, Activation of Sustainable…
ABU DHABI, United Arab Emirates–(BUSINESS WIRE)–The first WHO enlisted global clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to…
Awarded 1 Million € in non-dilutive Deep Tech funding, an initiative which supports advanced biotechnologies that are highly differentiated with…
MILWAUKEE–(BUSINESS WIRE)–The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its…
MILWAUKEE–(BUSINESS WIRE)–The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its…
MILWAUKEE–(BUSINESS WIRE)–The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its…
MILWAUKEE–(BUSINESS WIRE)–The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that its licensing partner Specialised Therapeutics Asia (STA) has…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that its licensing partner Specialised Therapeutics Asia (STA) has…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that its licensing partner Specialised Therapeutics Asia (STA) has…